Pls send inquiry to info@nbinno.com if you have any interests, thank you!
Related News: The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.2,5-dichloroaniline Advanced clinical trials with the Company’s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.Methyltris(tert-butylperoxy)silane CAS:10196-45-9 ICIG is a privately owned industrial holding company focusing on mid-sized chemicals and pharmaceutical businesses.5-Fluoro-6-Methylpyridin-2-aMine “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.Using a proprietary chemistry platform, Onconova has created a pipeline of targeted agents designed to work against specific cellular pathways that are important in cancer cells.
![](https://www.nbinno.com/upload/ad/1594704186835765.png)